Synbiotics Sample Clauses

Synbiotics. Synbiotics shall supply to Agen , upon a respective order by Agen ("Agen Order"), Agen's requirements of Synbiotics Biologicals of a quantity and quality as necessary for Agen to manufacture ICT Products consistent with Agen's requirements and quality standards. Each Agen Order shall specify the quantity, requested shipment method, and requested schedule and delivery destination for ordered Synbiotics Biologicals ` and Synbiotics shall promptly confirm each such Agen Order in writing. Synbiotics shall pay all costs of insurance, packaging, transportation and shipment of Synbiotics Biologicals. Each Agen Order shall be governed by and subject to the terms and conditions of this Agreement (regardless of whether such Agen Order references this Agreement). Any terms, conditions or provisions contained in any Agen Order or other Agen document that are different from or in addition to those contained in this Agreement are hereby expressly rejected and will not apply to any order for, or shipment of, Synbiotics Biologicals by Synbiotics. Agen acknowledges that Synbiotics is unwilling to supply Synbiotics Biologicals under any such different or additional terms, conditions or provisions. No conduct by Synbiotics, including, without limitation, shipment of Synbiotics Biologicals, shall constitute, or be construed to constitute, Synbiotics' consent to or recognition of a contract containing terms, conditions or provisions that are different from or are not contained in this Agreement.
Sample 1
AutoNDA by SimpleDocs

Related to Synbiotics

  • API If the Software offers integration capabilities via an API, your use of the API may be subject to additional costs or Sage specific policies and terms and conditions (which shall prevail in relation to your use of the API). You may not access or use the API in any way that could cause damage to us or the Software, or in contravention of any applicable laws. We reserve the right in our sole discretion, to: (i) update any API from time to time; (ii) place limitations around your use of any API; and (iii) deny you access to any API in the event of misuse by you or to otherwise protect our legitimate interests.

  • Technology Research Analyst Job# 1810 General Characteristics Maintains a strong understanding of the enterprise’s IT systems and architectures. Assists in the analysis of the requirements for the enterprise and applying emerging technologies to support long-term business objectives. Responsible for researching, collecting, and disseminating information on emerging technologies and key learnings throughout the enterprise. Researches and recommends changes to foundation architecture. Supports research projects to identify and evaluate emerging technologies. Interfaces with users and staff to evaluate possible implementation of the new technology in the enterprise, consistent with the goal of improving existing systems and technologies and in meeting the needs of the business. Analyzes and researches process of deployment and assists in this process.

  • Speech Therapy This plan covers speech therapy services when provided by a qualified licensed provider and part of a formal treatment plan for: • loss of speech or communication function; or • impairment as a result of an acute illness or injury, or an acute exacerbation of a chronic disease. Speech therapy services must relate to: • performing basic functional communication; or • assessing or treating swallowing dysfunction. See Autism Services when speech therapy services are rendered as part of the treatment of autism spectrum disorder. The amount you pay and any benefit limit will be the same whether the services are provided for habilitative or rehabilitative purposes.

  • Manufacturing Technology Transfer With respect to each Technology Transfer Product, upon AbbVie’s written request after the Inclusion Date for the Included Target to which such Technology Transfer Product is Directed, Morphic shall effect a full transfer to AbbVie or its designee (which designee may be an Affiliate or a Third Party manufacturer) of all Morphic Know-How and Joint Know-How relating to the then-current process for the Manufacture of such Technology Transfer Product (the “Manufacturing Process”) and to implement the Manufacturing Process at facilities designated by AbbVie (such transfer and implementation, as more fully described in this Section 5.3, the “Manufacturing Technology Transfer”). To assist with the Manufacturing Technology Transfer, Morphic will make its personnel reasonably available to AbbVie during normal business hours for up to [***] FTE hours with respect to each Included Target (in each case, free of charge to AbbVie) to transfer and implement the Manufacturing Process under this Section 5.3. Thereafter, if requested by AbbVie, Morphic shall continue to perform such obligations; provided, that AbbVie will reimburse Morphic for its full-time equivalent (FTE) costs (for clarity, in excess of [***] FTE hours) and any reasonable and verifiable out-of-pocket costs incurred in providing such assistance. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.

  • Licensee Licensee represents and warrants that:

  • Radiation Therapy/Chemotherapy Services This plan covers chemotherapy and radiation services. Respiratory Therapy This plan covers respiratory therapy services. When respiratory services are provided in your home, as part of a home care program, durable medical equipment, supplies, and oxygen are covered as a durable medical equipment service.

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Principal Investigator The Research will be supervised by __________________ ("Principal Investigator"). If for any reason the individual is unable to continue to serve as Principal Investigator and a successor acceptable to both the University and the Sponsor is not available, this agreement shall be terminated as provided in Article 9. The Principal Investigator may work with others at the University (“Associates”) in conducting the Research.

  • SMT XXXXXXXXX XXX, (PAN: XXXXX0000X), wife of Xxx Xxxxxx Xxx, by Nationality Indian, by faith Hindu, by occupation Housewife, residing at Village- Akrampur, PIN-743263, P.O. Akrampur, P.S. Habra, District North 24 Parganas, State West Bengal and (6) SRI XXXXXX XXX, (PAN-XXXXX0000X), son of Xxx Xxxxx Xxxxxx Dey, by Nationality Indian, by faith Hindu, by occupation Service, residing at Village- Akrampur, PIN – 743263, P.O. Akrampur, P.S. Habra, District North 24 Parganas, State West Bengal, hereinafter called and referred to as the VENDORS, all being represented by their Constituted Attorney, XXX XXXXX XXXXXX, (PAN: XXXXX0000X), son of Xxx Xxxxx Xxxxxx, by nationality Indian, by faith Hindu, by occupation Business, residing at BE-111, Sector-I, Salt Lake, Kolkata-700064, Post Office AE Market (Salt Lake City), Police Station Bidhannagar (North), District North 24 Parganas, and being one of the Directors of MAGNOLIA INFRASTRUCTURE DEVELOPMENT LIMITED, (CIN: U70200WB2010PLC152199), (PAN-XXXXX0000X), a Company incorporated under the provisions of the Companies Act, 1956 and having its registered office at 00, Xx. Xxxxxx Xxxxxxx Banerjee Road, Kolkata-700010, Post Office Beliaghata, Police Station: Beliaghata, District South 24 Parganas vide (1) Development Power of Attorney after registration of Development Agreement dated 12th September 2015 registered in the Office of the Additional District Sub-Registrar, Kadambagachi, North 24 Parganas and recorded in Book-I, Volume No. 1519-2015, at Pages 18496 to 18541, being No. 151901639 for the year 2015 and (2) Development Power of Attorney after registration of Development Agreement dated 19th November 2018 registered in the Office of the Additional District Sub-Registrar, Kadambagachi, North 24 Parganas and recorded in Book-I, Volume No. 1519-2015, at Pages 80220 to 80243, being No. 151903193 for the year 2018 (which expression shall unless excluded by or repugnant to the subject or context be deemed to mean and include their respective successors – interest and/or assigns) of the ONE PART. AND MAGNOLIA INFRASTRUCTURE DEVELOPMENT LIMITED, (CIN: U70200WB2010PLC152199), (PAN-XXXXX0000X), a Company incorporated under the provisions of the Companies Act, 1956 and having its registered office at 00, Xx. Xxxxxx Xxxxxxx Banerjee Road, Kolkata -700010, Post Office Beliaghata, Police Station: Beliaghata, District South 24 Parganas, being represented by its Director, XXX XXXXX XXXXXX, (PAN: XXXXX0000X), (AADHAAR NO: 000000000000), son of Xxx Xxxxx Xxxxxx, by nationality Indian, by faith Hindu, by occupation Business, residing at XX-000, Xxxxxx-X, Xxxx Xxxx, Xxxxxxx- 000000, Post Office AE Market (Salt Lake City), Police Station Bidhannagar (North), District North 24 Parganas, hereinafter called and referred to as the “DEVELOPER” (which expression shall unless repugnant to the context or meaning thereof shall include its successors-in-interest and/or permitted assigns of the SECOND PART. AND

  • University Any notice may be served upon the University by delivering it, in writing, to the University at the address set forth on the last page of this Agreement, by depositing it in a United States Postal Service deposit box with the postage fully prepaid and with the notice addressed to the University at the aforementioned address, or by sending a facsimile of it to the University facsimile number set forth on the last page of this Agreement.

Time is Money Join Law Insider Premium to draft better contracts faster.